CRISPR Germline Editing Reverberates Through Biotech Industry
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
The ethics of clinical applications of germline genome modification: a systematic review of reasons.
van Dijke I, Bosch L, Bredenoord A, Cornel M, Repping S, Hendriks S Hum Reprod. 2018; 33(9):1777-1796.
PMID: 30085071 PMC: 6454467. DOI: 10.1093/humrep/dey257.
References
1.
Johnson J, Canning J, Kaneko T, Pru J, Tilly J
. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature. 2004; 428(6979):145-50.
DOI: 10.1038/nature02316.
View
2.
Woods D, White Y, Tilly J
. Purification of oogonial stem cells from adult mouse and human ovaries: an assessment of the literature and a view toward the future. Reprod Sci. 2012; 20(1):7-15.
PMC: 3676240.
DOI: 10.1177/1933719112462632.
View
3.
Baltimore D, Berg P, Botchan M, Carroll D, Charo R, Church G
. Biotechnology. A prudent path forward for genomic engineering and germline gene modification. Science. 2015; 348(6230):36-8.
PMC: 4394183.
DOI: 10.1126/science.aab1028.
View
4.
Lanphier E, Urnov F, Haecker S, Werner M, Smolenski J
. Don't edit the human germ line. Nature. 2015; 519(7544):410-1.
DOI: 10.1038/519410a.
View